Position in IMNM
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$2,523,141
-$14,222,194 QoQ
Shares Held
115,370
-85.2% QoQ
Ownership
0.102%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2021
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in IMNM Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ExodusPoint Capital Management, LP holds $275,349,927 across 101 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CYTK |
Cytokinetics Inc
|
249,259 | $21,234,374 | |
| 2 | BBIO |
BridgeBio Pharma, Inc.
|
224,927 | $16,752,562 | |
| 3 | ORKA |
Oruka Therapeutics, Inc.
|
148,212 | $14,105,336 | |
| 4 | VKTX |
Viking Therapeutics, Inc.
|
361,126 | $14,087,525 | |
| 5 | JAZZ |
Jazz Pharmaceuticals plc
|
53,201 | $12,819,844 | |
| 6 | NAMS |
NewAmsterdam Pharma Co N.V.
|
304,334 | $10,313,879 | |
| 7 | TGTX |
Tg Therapeutics, Inc.
|
164,513 | $9,038,344 | |
| 8 | DNLI |
Denali Therapeutics Inc.
|
336,567 | $8,656,503 |
All Filings in IMNM
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,523,141 | 115,370 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $16,745,335 | 779,578 | Shares | Sole | 2026-02-17 | |
| 2025-06-30 | $761,418 | 81,873 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $687,489 | 102,153 | Shares | Sole | 2025-05-14 | |
| 2024-03-31 | $863,577 | 34,991 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $354,619 | 33,142 | Shares | Sole | 2024-02-14 | |
| 2021-06-30 | $221,440 | 12,800 | Shares | Sole | 2021-08-16 | |
| No filing history on record for this holder in this stock. | ||||||